DDN Bend Article

Control Issues: Bend Research and Catalent Partner to Provide Integrated Solutions For Oral Controlled Release Technologies

Author: Jeffrey Bouley, DDN

Bend Research Inc. and Catalent Pharma Solutions enter into an agreement to provide integrated solutions for pharmaceutical companies that are seeking to develop and manufacture specialized multiparticulate oral controlled-release products. The team-up is particularly focused on bringing complex controlled-release products to market faster and more efficiently with optimal therapeutic and release profiles.

DOWNLOAD PDF